Your English writing platform
Discover LudwigExact(60)
Eligible patients could enroll into this continuation study directly after completing the 6-month extension study.
Nineteen of 57 patients completed the extension study.
An additional phase 2 open label extension study is recruiting.
In this extension study, however, they did not continue increasing.
There were no deaths in the extension study.
No primary endpoint was defined for the extension study.
No unexpected AEs were reported in the extension study.
Oral glucocorticoids were allowed in the open extension study.
EC was the medical monitor for the extension study.
Results were similar relative to extension study baseline.
The final extension study visit took place in January 2012.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com